Endocrinological activities of ghrelin: New insights

European Journal of Internal Medicine

Volumn 14, Issue 6, 2003, Pages 351-356

  Ukkola, Olavi ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Cortisol; Ghrelin; Growth hormone; Hypothalamus; Pituitary; Prolactin

Indexed keywords

GHRELIN; GLUCAGON; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HYDROCORTISONE; INSULIN; OCTREOTIDE; SOMATOSTATIN;

ACROMEGALY; ADENOHYPOPHYSIS; DRUG EFFECT; DRUG POTENCY; ENDOCRINE GLAND; ENDOCRINOLOGY; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE DEFICIENCY; HORMONE RELEASE; HUMAN; HYPOGLYCEMIA; NONHUMAN; OBESITY; PRADER WILLI SYNDROME; REVIEW;

EID: 4344680499     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(03)90000-8     Document Type: Review

References (59)

1. Kojima M, Hosoda H, Date Y et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-60.
2. Bednarek MA, Feighner SD, Pong SS et al. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J Med Chem 2000;43:4370-6.
3. Torsello A, Ghe' C, Bresciani E et al. Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo. Endocrinology 2002;143:1968-71.
4. Tamura H, Kamegai J, Shimizu T et al. Ghrelin stimulates GH but not food intake in arcuate nucleus ablated rats. Endocrinology 2002;143:3268-75.
5. Korbonits M, Kojima M, Kangawa K, Grossman AB. Presence of ghrelin in normal and adenomatous human pituitary. Endocrine 2001;14:101-4.
6. Garcia A, Alvarez CV, Smith RG, Dieguez C. Regulation of Pit-1 expression by ghrelin and GHRP-6 through the GH secretagogue receptor. Mol Endocrinol 2001;15:1484-95.
7. Shuto Y, Shibasaki T, Otagiri A et al. Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J Clin Invest 2002;109:1429-36.
8. Date Y, Murakami N, Kojima M et al. Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats. Biochem Biophys Res Commun 2000;28:477-80.
9. Seoane LM, Tovar S, Baldelli R et al. Ghrelin elicits a marked stimulatory effect on GH secretion in freely-moving rats. Eur J Endocrinol 2000;143:R7-9.
10. Arvat E, Di Vito L, Broglio F et al. Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 2000;23:493-5.
11. Tolle V, Bassant MH, Zizzari P et al. Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats. Endocrinology 2002;143:1353-61.
12. Tolle V, Kadem M, Bluet-Pajot MT et al. Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. J Clin Endocrinol Metab 2003;88:109-16.
13. Tannenbaum GS, Epelbaum J, Bowers CY. Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion. Endocrinology 2003;144:967-74.
14. Schaller G, Schmidt A, Pleiner J et al. Plasma ghrelin concentrations are not regulated by glucose or insulin: a double-blind, placebo-controlled crossover clamp study. Diabetes 2003;52:16-20.
15. Norrelund H, Hansen TK, Orskov H et al. Ghrelin immunoreactivity in human plasma is suppressed by somatostatin. Clin Endocrinol 2002;57:539-46.
16. Broglio F, Benso A, Gottero C et al. Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans. Clin Endocrinol 2002;57:265-71.
17. Di Vito L, Broglio F, Benso A et al. The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans. Clin Endocrinol 2002;56:643-8.
18. Broglio F, Koetsveld PvP, Benso A et al. Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. J Clin Endocrinol Metab 2002;87:4829-32.
19. Seoane LM, Lopez M, Tovar S et al. Agouti-related peptide, neuropeptide y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus. Endocrinology 2003;144:544-51.
20. Deghenghi R, Papotti M, Ghigo E, Muccioli G. Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland. J Endocrinol Invest 2001;24:RC1-3.
21. Tannenbaum GS, Bowers CY. Interactions of growth hormone secretagogues and growth hormone-releasing hormone/somatostatin. Endocrine 2001;14:21-7.
22. Kamegai J, Tamura H, Shimizu T et al. Regulation of the ghrelin gene: growth hormone-releasing hormone upregulates ghrelin mRNA in the pituitary. Endocrinology 2001;142:4154-7.
23. Hataya Y, Akamizu T, Takaya K et al. A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 2001;86:4552.
24. Yamazaki M, Nakamura K, Kobayashi H et al. Regulational effect of ghrelin on growth hormone secretion from perifused rat anterior pituitary cells. J Neuroendocrinol 2002;14:156-62.
25. Wren AM, Small CJ, Fribbens CV et al. The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology 2002;76:316-24.
26. Ishizaki S, Murase T, Sugimura Y et al. Role of ghrelin in the regulation of vasopressin release in conscious rats. Endocrinology 2002;143:589-1593.
27. Furuta M, Funabashi T, Kimura F. Intracerebroventricular administration of ghrelin rapidly suppresses pulsatile luteinizing hormone secretion in ovariectomized rats. Biochem Biophys Res Commun 2001;288:780-5.
28. Takaya K, Ariyasu H, Kanamoto N et al. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 2000;85:4908-11.
29. Weikel JC, Wichniak A, Ising M et al. Ghrelin promotes slow-wave sleep in man. Am J Physiol Endocrinol Metab 2003;284:E407-15.
30. Arvat E, Maccario M, Di Vito L et al. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 2001;86:1169-74.
31. Broglio F, Gottero C, Benso A et al. Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans. Clin Endocrinol (Oxf) 2003;58:92-8.
32. Wren AM, Small CJ, Ward HL et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000;141:4325-8.
33. Enomoto M, Nagaya N, Uematsu M, et al. Cardiovascular and hormonal effects of subcutaneous administration of Ghrelin, a novel growth hormone-releasing peptide, in healthy humans. Clin Sci (Lond) 2003;29 [e-published ahead of print].
34. Tena-Sempere M, Barreiro ML, Gonzalez LC et al. Novel expression and functional role of ghrelin in rat testis. Endocrinology 2002;143:717-25.
35. Gualillo O, Caminos JE, Kojima M et al. Gender and gonadal influences on ghrelin mRNA levels in rat stomach. Eur J Endocrinol 2001;144:687-90.
36. Gaytan F, Barreiro ML, Chopin LK et al. Immunolocalization of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in the cyclic human ovary. J Clin Endocrinol Metab 2003;88:879-87.
37. Pagotto U, Gambineri A, Vicennati V et al. Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels. J Clin Endocrinol Metab 2002;87:5625-9.
38. Barreiro ML, Pinilla L, Aguilar E, Tena-Sempere M. Expression and homologous regulation of GH secretagogue receptor mRNA in rat adrenal gland. Eur J Endocrinol 2002;147:677-88.
39. Volante M, Allia E, Fulcheri E et al. Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth. Am J Pathol 2003;162:645-54.
40. Kanamoto N, Akamizu T, Hosoda H et al. Substantial production of ghrelin by a human medullary thyroid carcinoma cell line. J Clin Endocrinol Metab 2001;86:4984-90.
41. Caminos JE, Seoane LM, Tovar SA, Casanueva FF, Dieguez C. Influence of thyroid status and growth hormone deficiency on ghrelin. Eur J Endocrinol 2002;147:159-63.
42. Muller AF, Lamberts SW, Janssen JA et al. Ghrelin drives GH secretion during fasting in man. Eur J Endocrinol 2002;146:203-7.
43. Flanagan DE, Evans ML, Monsod TP et al. The influence of insulin on circulating ghrelin. Am J Physiol Endocrinol Metab 2003;284:E313-6.
44. Lucidi P, Murdolo G, Di Loreto C et al. Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia. Diabetes 2002;51:2911-4.
45. Aimaretti G, Baffoni C, Broglio F et al. Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency. Clin Endocrinol 2002;56:765-71.
46. Janssen JA, van der Toorn FM, Hofland LJ et al. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy. Eur J Endocrinol 2001;145:711-6.
47. Dall R, Kanaley J, Hansen TK et al. Plasma ghrelin levels during exercise in healthy subjects and in growth hormone-deficient patients. Eur J Endocrinol 2002;147:65-70.
48. Lee HM, Wang G, Englander EW, Kojima M, Greeley Jr. GH. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 2002;143:85-190.
49. Tschöp M, Flora DB, Mayer JP, Heiman ML. Hypophysectomy prevents ghrelin-induced adiposity and increases gastric ghrelin secretion in rats. Obes Res 2002;10:991-9.
50. Cummings DE, Clement K, Purnell JQ et al. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med 2002;8:643-4.
51. DelParigi A, Tschöp M, Heiman ML et al. High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome. J Clin Endocrinol Metab 2002;87:5461-4.
52. van der Toorn FM, Janssen JA, de Herder WW et al. Central ghrelin production does not substantially contribute to systemic ghrelin concentrations: a study in two subjects with active acromegaly. Eur J Endocrinol 2002;147:195-9.
53. Cappiello V, Ronchi C, Morpurgo PS et al. Circulating ghrelin levels in basal conditions and during glucose tolerance test in acromegalic patients. Eur J Endocrinol 2002;147:189-94.
54. Freda PU, Reyes CM, Conwell IM, Sundeen RE, Wardlaw SL. Serum ghrelin levels in acromegaly: effects of surgical and long-acting octreotide therapy. J Clin Endocrinol Metab 2003;88:2037-44.
55. Maccario M, Tassone F, Grottoli S et al. Neuroendocrine and metabolic determinants of the adaptation of GH/IGF-I axis to obesity. Ann Endocrinol (Paris) 2002;63:140-4.
56. Okumura H, Nagaya N, Enomoto M et al. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J Cardiovasc Pharmacol 2002;39:779-83.
57. Bellone S, Rapa A, Vivenza D et al. Circulating ghrelin levels as function of gender, pubertal status and adiposity in childhood. J Endocrinol Invest 2002;25:RC13-5.
58. Lindeman JH, Pijl H, Van Dielen FM et al. Ghrelin and the hyposomatotropism of obesity. Obes Res 2002;10:1161-6.
59. Rigamonti AE, Pincelli AI, Corra B et al. Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients. J Endocrinol 2002;175:R1-5.